Amaero (3DA) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
28 Oct, 2026Company overview and business model
U.S. producer of high-purity refractory and titanium alloy spherical powders for additive manufacturing, plus large near-net-shape components made via powder metallurgy hot isostatic pressing (PM-HIP).
EIGA Premium crucible-free atomization targets low-contamination powders for defense, aerospace, space, medical and industrial uses; PM-HIP offers a domestic alternative to large castings and forgings.
Tennessee facility commissioned three atomizers by June 2026; annual planned capacity is 680 metric tons, with a fourth atomizer expected in June 2027 to raise planned capacity to 920 metric tons.
Long-term supply and distribution arrangements include ADDMAN, Velo3D, Titomic, Knust-Godwin and United Performance Metals; July 2026 backlog was $15.3 million across 26 customers.
Financial performance and metrics
FY2025 revenue was $6.3 million versus $1.3 million in FY2024; gross loss widened to $5.2 million from $2.8 million and net loss increased to $18.4 million from $12.7 million.
H1 2026 revenue rose to $7.4 million from $1.2 million YoY; gross loss narrowed to $3.1 million from $3.3 million, while net loss widened to $13.4 million from $8.7 million.
Adjusted EBITDA loss was $8.5 million in H1 2026 versus $7.5 million in H1 2025; operating cash outflow was $12.9 million versus $7.0 million.
At June 30, 2026, cash and cash equivalents were $13.6 million, net debt was $19.6 million, and accumulated deficit was $75.5 million; management cited substantial going-concern doubt without the offering or other financing.
Backlog increased from $0.4 million at Dec. 31, 2024 to $6.9 million at Dec. 31, 2025, $10.0 million at June 30, 2026 and $15.3 million at July 31, 2026.
Use of proceeds and capital allocation
Up to an unspecified portion of net proceeds is intended for capital equipment over the next 12 months; remaining proceeds are planned for working capital, operating expenses and R&D.
Proceeds may also fund acquisitions or investments in businesses, products, services or technologies; no material acquisition or investment commitments were in place at filing.
The offering is intended to increase capitalization and financial flexibility, create a U.S. public market, broaden future access to U.S. equity markets and raise marketplace visibility.
Latest events from Amaero
- Capacity expansion and rising backlog meet a sharp funding and execution test.3DA
Registration filing - A $15.7m IPO funds capacity growth, but substantial going-concern doubt remains.3DA
Registration filing - A domestic advanced-materials scale-up seeks IPO capital amid losses and execution risks.3DA
Registration filing - Stockholders voted on equity plans, share issuance, and director compensation changes.3DA
EGM 2026 - Revenue up 376% to $18.1M, but net loss widened; strong backlog amid going concern risk.3DA
H2 2026 - Record revenue growth, strong backlog, and U.S. IPO plans mark a pivotal year.3DA
Q4 2026 TU - Poised for rapid growth, Amaero leads U.S. advanced powder production and targets a U.S. IPO.3DA
IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 - Shareholders and option holders strongly approved all proposed schemes and director option grants.3DA
Scheme Meeting 2026 presentation - Q3 FY2026 revenue up 301%–347% YoY, FY2026 fully contracted, U.S. redomiciliation advances.3DA
Q3 2026 TU